Tag: Goldfinch Bio

April 30, 2020 Off

Goldfinch Bio Expands Executive Leadership Team

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney disease, today announced the appointment of Kyle Kuvalanka as Chief Financial and Operating Officer and the promotion of Lori Rudolph-Owen, Ph.D., from Senior Vice President, R&D Strategy and Operations to Chief Development Officer, effective immediately.